Hall B, Amin N, Veeranna , Hisanaga S, Kulkarni A
Neurochem Res. 2024; 49(12):3181-3186.
PMID: 39235580
PMC: 11502590.
DOI: 10.1007/s11064-024-04234-5.
Noll J, Sherafat A, Ford G, Ford B
Front Cell Neurosci. 2024; 18:1325630.
PMID: 38638304
PMC: 11024452.
DOI: 10.3389/fncel.2024.1325630.
Bao L, Lan X, Zhang G, Bao X, Li B, Ma D
Transl Neurosci. 2023; 14(1):20220318.
PMID: 37901140
PMC: 10612488.
DOI: 10.1515/tnsci-2022-0318.
Ahmad M, Kruger B, Kroll T, Vettorazzi S, Dorn A, Mengele F
Bone Res. 2022; 10(1):33.
PMID: 35383146
PMC: 8983726.
DOI: 10.1038/s41413-022-00195-z.
Yoo Y, Joo S
Int J Mol Sci. 2021; 22(21).
PMID: 34768769
PMC: 8583535.
DOI: 10.3390/ijms222111341.
Darpp-32 and t-Darpp protein products of PPP1R1B: Old dogs with new tricks.
Avanes A, Lenz G, Momand J
Biochem Pharmacol. 2018; 160:71-79.
PMID: 30552871
PMC: 6360145.
DOI: 10.1016/j.bcp.2018.12.008.
Neuregulin-1β Plays a Neuroprotective Role by Inhibiting the Cdk5 Signaling Pathway after Cerebral Ischemia-Reperfusion Injury in Rats.
Zhang R, Liu C, Ji Y, Teng L, Guo Y
J Mol Neurosci. 2018; 66(2):261-272.
PMID: 30206770
DOI: 10.1007/s12031-018-1166-3.
Dysregulation of Neuregulin-1/ErbB signaling in the hippocampus of rats after administration of doxorubicin.
Liao D, Guo Y, Xiang D, Dang R, Xu P, Cai H
Drug Des Devel Ther. 2018; 12:231-239.
PMID: 29430172
PMC: 5796460.
DOI: 10.2147/DDDT.S151511.
Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration.
Sami N, Kumar V, Islam A, Ali S, Ahmad F, Hassan I
Mol Neurobiol. 2016; 54(7):5085-5106.
PMID: 27544236
DOI: 10.1007/s12035-016-0046-5.
CDK5 downregulation enhances synaptic plasticity.
Posada-Duque R, Ramirez O, Hartel S, Inestrosa N, Bodaleo F, Gonzalez-Billault C
Cell Mol Life Sci. 2016; 74(1):153-172.
PMID: 27506619
PMC: 11107552.
DOI: 10.1007/s00018-016-2333-8.
The O-GlcNAc Modification of CDK5 Involved in Neuronal Apoptosis Following In Vitro Intracerebral Hemorrhage.
Ning X, Tao T, Shen J, Ji Y, Xie L, Wang H
Cell Mol Neurobiol. 2016; 37(3):527-536.
PMID: 27316643
PMC: 11482199.
DOI: 10.1007/s10571-016-0391-y.
Differential changes in Neuregulin-1 signaling in major brain regions in a lipopolysaccharide-induced neuroinflammation mouse model.
Yang Z, Jiang Q, Chen S, Hu C, Shen H, Huang P
Mol Med Rep. 2016; 14(1):790-6.
PMID: 27220549
PMC: 4918623.
DOI: 10.3892/mmr.2016.5325.
APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis.
Hong S, Lee W, Kim Y, Kim H, Jeon Y, Lim B
Oncotarget. 2016; 7(16):21601-17.
PMID: 26942872
PMC: 5008309.
DOI: 10.18632/oncotarget.7802.
Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
Sun S, Zhou X, Huang Y, Kong L, Mei M, Guo W
Mol Cancer. 2015; 14:213.
PMID: 26690371
PMC: 4687320.
DOI: 10.1186/s12943-015-0487-x.
Bioinformatics Knowledge Map for Analysis of Beta-Catenin Function in Cancer.
Celen I, Ross K, Arighi C, Wu C
PLoS One. 2015; 10(10):e0141773.
PMID: 26509276
PMC: 4624812.
DOI: 10.1371/journal.pone.0141773.
Cyclin-dependent kinase 5 activates guanine nucleotide exchange factor GIV/Girdin to orchestrate migration-proliferation dichotomy.
Bhandari D, Lopez-Sanchez I, To A, Lo I, Aznar N, Leyme A
Proc Natl Acad Sci U S A. 2015; 112(35):E4874-83.
PMID: 26286990
PMC: 4568279.
DOI: 10.1073/pnas.1514157112.
Neuregulin-1β Regulates the migration of Different Neurochemical Phenotypic Neurons from Organotypically Cultured Dorsal Root Ganglion Explants.
Li Y, Liu G, Li H, Bi Y
Cell Mol Neurobiol. 2015; 36(1):69-81.
PMID: 26093851
PMC: 11482311.
DOI: 10.1007/s10571-015-0221-7.
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains.
Stuhlmiller T, Miller S, Zawistowski J, Nakamura K, Beltran A, Duncan J
Cell Rep. 2015; 11(3):390-404.
PMID: 25865888
PMC: 4408261.
DOI: 10.1016/j.celrep.2015.03.037.
p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing.
Posada-Duque R, Lopez-Tobon A, Piedrahita D, Gonzalez-Billault C, Cardona-Gomez G
J Neurochem. 2015; 134(2):354-70.
PMID: 25864429
PMC: 4491027.
DOI: 10.1111/jnc.13127.
Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells.
Lindqvist J, Imanishi S, Torvaldson E, Malinen M, Remes M, Orn F
Mol Biol Cell. 2015; 26(11):1971-84.
PMID: 25851605
PMC: 4472009.
DOI: 10.1091/mbc.E14-12-1634.